BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 23012689)

  • 1. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
    Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K
    Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation.
    Bang CN
    Dan Med J; 2013 Oct; 60(10):B4731. PubMed ID: 24083535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease.
    Kulik A; Singh JP; Levin R; Avorn J; Choudhry NK
    Am J Cardiol; 2010 Jun; 105(12):1655-60. PubMed ID: 20538110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.
    Bang CN; Gislason GH; Greve AM; Bang CA; Lilja A; Torp-Pedersen C; Andersen PK; Køber L; Devereux RB; Wachtell K
    J Am Heart Assoc; 2014 Jan; 3(1):e000382. PubMed ID: 24449803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
    Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
    J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting.
    Karimi A; Bidhendi LM; Rezvanfard M; Bina P; Yousefi A; Molai M; Zare E; Fathollahi MS; Sadeghian S
    Ann Thorac Surg; 2012 Jul; 94(1):8-14. PubMed ID: 22429672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with statin selection among privately insured commercial and Medicare patients.
    Zhao Z; Bae J; Sponseller CA; Zhu Y; Kryzhanovski VA; LeNarz LA
    Curr Med Res Opin; 2013 Apr; 29(4):395-404. PubMed ID: 23406054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
    Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis.
    Bang CN; Greve AM; Abdulla J; Køber L; Gislason GH; Wachtell K
    Int J Cardiol; 2013 Aug; 167(3):624-30. PubMed ID: 22999824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Atrial Fibrillation and Costs After Myocardial Infarction: A Community Study.
    Borah BJ; Roger VL; Mills RM; Weston SA; Anderson SS; Chamberlain AM
    Clin Cardiol; 2015 Sep; 38(9):548-54. PubMed ID: 26418757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.
    Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use after acute myocardial infarction: a nationwide study in Denmark.
    Rasmussen JN; Gislason GH; Abildstrom SZ; Rasmussen S; Gustafsson I; Buch P; Friberg J; Køber L; Torp-Pedersen C; Madsen M; Stender S
    Br J Clin Pharmacol; 2005 Aug; 60(2):150-8. PubMed ID: 16042668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.
    Ho LT; Lin LY; Yang YH; Wu CK; Juang JM; Wang YC; Tsai CT; Lai LP; Hwang JJ; Chiang FT; Lin JL; Chen PC
    Int J Cardiol; 2015 Dec; 201():538-43. PubMed ID: 26322603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
    Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
    Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion.
    Naji F; Suran D; Kanic V; Vokac D; Sabovic M
    Int Heart J; 2009 Mar; 50(2):153-60. PubMed ID: 19367026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.